Rockefeller Capital Management L.P. reports 11.32% increase in ownership of ABL / Abbott Laboratories

Abbott Laboratories

DE ˙ XTRA ˙ US0028241000

75,22 € ↑1,20 (1,62%)

2026-06-03
AKTIENPREIS

Security	DE:ABL / Abbott Laboratories
Institution	Rockefeller Capital Management L.P.
Latest Disclosed Ownership	1,533,594 shares
Latest Disclosed Value	$ 157,454,336

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 1,533,594 shares of Abbott Laboratories (DE:ABL) valued at $136,213,819 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 1,377,659 shares of Abbott Laboratories. This represents a change in shares of 11.32% during the quarter. The current value of the position is $115,356,941 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-14	2026-03-31	13F	ABBOTT LABORATORIES	COM	002824100	1,533,594	155,935	11.32	157,454	-8.78	0.2792
2026-03-16	2025-12-31	13F/A-1	ABBOTT LABS	COM	002824100	1,377,659	297,268	27.51	172,607	19.28	0.3108
2026-02-14	2025-12-31	13F	ABBOTT LABS	COM	002824100	2,948,458	1,868,067		172,042		0.1570
2025-11-14	2025-09-30	13F	ABBOTT LABS	COM	002824100	1,080,391	73,815	7.33	144,708	5.70	0.2831
2025-08-14	2025-06-30	13F/A-1	ABBOTT LABS	COM	002824100	1,006,576	142,467	16.49	136,905	19.44	0.3002
2025-08-08	2025-06-30	13F	ABBOTT LABS	COM	002824100	1,005,706	141,597		136,786		0.1724
2025-05-14	2025-03-31	13F	ABBOTT LABS	COM	002824100	864,109	69,357	8.73	114,624	27.51	0.2829
2025-02-13	2024-12-31	13F	ABBOTT LABS	COM	002824100	794,752	129,495	19.47	89,895	18.52	0.2328
2024-11-14	2024-09-30	13F	ABBOTT LABS	COM	002824100	665,257	-11,032	-1.63	75,846	7.91	0.2041
2024-08-12	2024-06-30	13F	ABBOTT LABS	COM	002824100	676,289	-16,572	-2.39	70,288	-10.75	0.1998
2024-05-14	2024-03-31	13F	ABBOTT LABS	COM	002824100	692,861	-816	-0.12	78,751	3.14	0.2299
2024-02-14	2023-12-31	13F	ABBOTT LABS	COM	002824100	693,677	29,854	4.50	76,353	18.83	0.2551
2023-11-14	2023-09-30	13F	ABBOTT LABS	COM	002824100	663,823	35,993	5.73	64,254	-4.38	0.2478
2023-08-14	2023-06-30	13F	ABBOTT LABS	COM	002824100	627,830	192,868	44.34	67,198	152,620.45	0.2603
2023-05-16	2023-03-31	13F	ABBOTT LABS	COM	002824100	434,962	4,090	0.95	44	-99.91	0.1894
2023-03-06	2022-12-31	13F	ABBOTT LABS	COM	002824100	430,872	8,714	2.06	47,304	15.81	0.2377
2022-11-02	2022-09-30	13F	ABBOTT LABS	COM	002824100	422,158	61,441	17.03	40,847	4.23	0.2111
2022-08-12	2022-06-30	13F	ABBOTT LABS	COM	002824100	360,717	49,732	15.99	39,190	6.47	0.2082
2022-05-13	2022-03-31	13F	ABBOTT LABS	COM	002824100	310,985	-9,829	-3.06	36,807	-18.48	0.1775
2022-02-14	2021-12-31	13F	ABBOTT LABS	COM	002824100	320,814	7,791	2.49	45,150	22.11	0.2107
2021-11-12	2021-09-30	13F	ABBOTT LABS	COM	002824100	313,023	-28,691	-8.40	36,975	-6.66	0.1943
2021-08-10	2021-06-30	13F	ABBOTT LABS	COM	002824100	341,714	16,238	4.99	39,613	1.56	0.2232
2021-05-11	2021-03-31	13F	ABBOTT LABS	COM	002824100	325,476	8,256	2.60	39,003	12.30	0.2639
2021-02-12	2020-12-31	13F	ABBOTT LABS	COM	002824100	317,220	50,672	19.01	34,732	19.74	0.2631
2020-11-13	2020-09-30	13F	ABBOTT LABS	COM	002824100	266,548	-20,854	-7.26	29,007	10.39	0.2717
2020-08-12	2020-06-30	13F	ABBOTT LABS	COM	002824100	287,402	19,865	7.43	26,277	24.47	0.2750
2020-05-12	2020-03-31	13F	ABBOTT LABS	COM	002824100	267,537	-35,813	-11.81	21,111	-19.88	0.2769
2020-02-07	2019-12-31	13F	ABBOTT LABS	COM	002824100	303,350	17,822	6.24	26,349	10.30	0.3285
2019-11-12	2019-09-30	13F	ABBOTT LABS	COM	002824100	285,528	11,482	4.19	23,889	3.65	0.3241
2019-08-09	2019-06-30	13F	ABBOTT LABS	COM	002824100	274,046	-4,889	-1.75	23,048	3.36	0.3214
2019-05-10	2019-03-31	13F	ABBOTT LABS	COM	002824100	278,935	4,550	1.66	22,298	12.35	0.3178
2019-02-12	2018-12-31	13F	ABBOTT LABS	COM	002824100	274,385	-1,025	-0.37	19,847	-1.77	0.3478
2018-11-02	2018-09-30	13F	Abbott Laboratories	Common	002824100	275,410	-11,049	-3.86	20,204	15.64	0.3067
2018-07-31	2018-06-30	13F	Abbott Laboratories	Common	002824100	286,459	-2,454	-0.85	17,471	0.92	0.2845
2018-05-09	2018-03-31	13F	Abbott Laboratories	Common	002824100	288,913	288,913		17,312		0.2861

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.